You are here: Industry Insights > Biopharma

News List

2019 wraps up, biopharma's outlook is 'cautiously optimistic,' fiercepharma
January 13, 2019
The J.P. Morgan Healthcare Conference usually takes one of two tones.
2018 set benchmark for digital health investment – report pharmaphorum
January 09, 2019
Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.
Eli Lilly grabs spotlight at J.P. Morgan with $8B Loxo Oncology buyout fiercepharma
January 08, 2019
On the first day of biopharma’s largest confab, the J.P. Morgan Healthcare Conference, Eli Lilly confirmed that big-ticket M&A is back in fashion in the industry.
With Gilead and rivals deep in phase 3, FDA unveils draft guidance on NASH drug development fiercebiotech
January 02, 2019
The FDA has published draft guidance on developing NASH drugs that has implications for Gilead and the host of other companies targeting the indication.....
Long-awaited M&A boom will hit biopharma in 2019 despite persistent worries, prognosticators predict fiercepharma
December 20, 2018
When Congress passed a business-friendly tax package last year, pharma prognosticators predicted 2018 would be the year that mergers and acquisitions in the sector would finally gain steam.
Thorny path: A replay of how Tesaro got its $5.1B GlaxoSmithKline buyout fiercepharma
December 18, 2018
With its Tesaro buyout, GlaxoSmithKline CEO Emma Walmsley finally beefed up in oncology, one of the fields she tagged for growth about a year ago. For the small biotech, the sale marked the end of a longer and more arduous journey.
Rentschler Biopharma Buys U.S. Mfg. Site from Shire contractpharma
December 18, 2018
Rentschler Biopharma SE, a contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA.
Rentschler Biopharma Appoints Innovation SVP contractpharma
December 17, 2018
Dr. Zurdo will provide scientific leadership for development and manufacturing services from cell-line development through to final product manufacturing. He will also be responsible for managing key strategic collaborations and ensuring that Rentschler B
Baxter, Oasmia Ink Apealea Commercial Mfg. Pact pharmatimes
December 10, 2018
Oasmia Pharmaceutical AB signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.
Few biopharma buyouts in quiet third quarter evaluate
October 22, 2018
The $6.6bn of M&A deals announced by drug makers in third quarter of 2018 marks the slowest three-month period since 2013.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page